Wave Life Sciences Slips as Obesity Data Falls Short
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Retirement planning is essential for achieving financial stability in your later years. Learn why it's never too early to start planning.
21,478 articlesWave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Federal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
When headlines threaten to derail a stock you own, smart investors don’t panic. This guide explains how to evaluate M...
The U.S. federal debt surpassed $39 trillion for the first time, signaling a turning point for budgeting and markets....
Ark Invest disclosed a new Alphabet stake, triggering debate over Google’s growth drivers and the broader tech rally....
IonQ is leading the field among pure-play quantum stocks in 2026, delivering a positive year-to-date return while its...
Discover how Owens Corning 2025 earnings shape the stock's outlook. This guide breaks down Q4 results, margins, and t...
When the national debt climbs past the size of the economy, it can ripple through interest rates and monthly payments...
Vice Capital Markets launches a public daily Par Note Rate benchmark, providing a market-based view of mortgage prici...
Evaxion's Q1 2026 results shed light on how its AI-driven drug discovery model is translating into collaborations and...
As Absci releases its 2026 earnings outlook, investors gain a clearer view of runway, milestones, and collaboration p...
Barclays slashed Coinbase’s price target to $107 following aQ1 2026 revenue miss, highlighting a tug-of-war between c...